Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Capital Expenditures: 2019-2023

Historic Capital Expenditures for Praxis Precision Medicines (PRAX) over the last 5 years, with Dec 2023 value amounting to $50,000.

  • Praxis Precision Medicines' Capital Expenditures was N/A to -$8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $151,000, marking a year-over-year change of. This contributed to the annual value of $50,000 for FY2023, which is 88.74% down from last year.
  • According to the latest figures from FY2023, Praxis Precision Medicines' Capital Expenditures is $50,000, which was down 88.74% from $444,000 recorded in FY2022.
  • In the past 5 years, Praxis Precision Medicines' Capital Expenditures registered a high of $1.1 million during FY2021, and its lowest value of $4,000 during FY2020.
  • Moreover, its 3-year median value for Capital Expenditures was $444,000 (2022), whereas its average is $514,667.
  • Per our database at Business Quant, Praxis Precision Medicines' Capital Expenditures slumped by 96.12% in 2020 and then spiked by 26,150.00% in 2021.
  • Yearly analysis of 5 years shows Praxis Precision Medicines' Capital Expenditures stood at $103,000 in 2019, then slumped by 96.12% to $4,000 in 2020, then skyrocketed by 26,150.00% to $1.1 million in 2021, then tumbled by 57.71% to $444,000 in 2022, then slumped by 88.74% to $50,000 in 2023.